Literature DB >> 16309196

Effect of anticancer agents on codeinone-induced apoptosis in human cancer cell lines.

Risa Takeuchi1, Hiroshi Hoshijima, Noriko Onuki, Hiroshi Nagasaka, Shahead Ali Chowdhury, Masami Kawase, Hiroshi Sakagami.   

Abstract

The possible apoptosis-inducing activity of codeinone, an oxidative metabolite of codeine, without or with anticancer drugs, was investigated. Codeinone induced internucleosomal DNA fragmentation in human promyelocytic leukemia cells (HL-60), but not in human squamous cell carcinoma cells (HSC-2). Codeinone dose-dependently activated caspase-3 in both of these cells, but to a much lesser extent than that attained by actinomycin D. This property of codeinone was similar to what we have found previously in alpha,beta-unsaturated ketones. Codeinone did not activate caspase-8 or caspase-9 in these cells. The cytotoxic activity of codeinone against HSC-2 cells was inhibited by N-acetyl-L-cysteine, but somewhat additively stimulated by sodium ascorbate, epigallocatechin gallate, hydrogen peroxide, sodium fluoride, 5-fluorouridine, cisplatin, doxorubicin and methotrexate. These data suggest that codeinone has possible antitumor potential, in addition to its action as a narcotic analgesic, even though it induces incomplete apoptosis-associated characteristics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309196

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Sequential cytotoxicity: a theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids.

Authors:  Swagatika Das; Umashankar Das; Hiroshi Sakagami; Ken Hashimoto; Masami Kawase; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  Bioorg Med Chem Lett       Date:  2010-09-17       Impact factor: 2.823

2.  1-Aryl-2-dimethylaminomethyl-2-propen-1-one hydrochlorides and related adducts: A quest for selective cytotoxicity for malignant cells.

Authors:  Hari N Pati; Umashankar Das; Masami Kawase; Hiroshi Sakagami; Jan Balzarini; Erik De Clercq; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2008-03-27       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.